Ann: NDA Resubmission Accepted and Approval Date Confirmed, page-93

There's a couple of other biotech stocks that others have pointed me towards (but that I can't post here lest I get accused of cross -promoting) that have substantial catalysts coming to fruition early this year. I think there is potential there to make money and then jump back into BOT before FDA Approval (or even stay with the others for a bit more if their results are as good as hoped for). That said, maybe their results will be shite and I'll regret not just sitting tight with what I think is a longer-term winner!